CGeneTech (Suzhou, China) Co.
Latest round
- Series C
Last raised
- Sep 2024
Total raised
- $44M
Investors
- 7
About CGeneTech (Suzhou, China) Co.
, Ltd operates as a small molecule innovative drug developer that integrates R&D, production and clinical trial services. The founder, Qiang Yu, graduated from Peking University and The University of Kansas. The co-founder, Juping Ding, founded Beijing Mairuikai Medical Technology. It has been recognized as a Jiangsu Provincial Science and Technology Support Project Unit and its drugs has obtained clinical trial approval from the US FDA. The company also set up a Flash Release Preparation Engineering Technology Center. The company's integrated drug research and development technology platforms include a target and drug molecule spatial interaction technology platform and a precision anti-cancer drug development platform. Its drugs include DPP-4 inhibitor senagliptin, CXCR4 antagonist CGT-1881, and FGFR/VEGFR dual-target inhibitor CGT-6321. The drugs developed by the company can be used to treat hypoglycemic, anti-cancer and autoimmune diseases. CGeneTech generates revenue by developing innovative small molecule drugs that can be used to treat hypoglycemic, anti-cancer and autoimmune diseases.
Who invested in CGeneTech (Suzhou, China) Co.
7 investors across 4 rounds
See all investors in CGeneTech (Suzhou, China) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CGeneTech (Suzhou, China) Co.
Who invested in CGeneTech (Suzhou, China) Co.?
CGeneTech (Suzhou, China) Co. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CGeneTech (Suzhou, China) Co. raised?
CGeneTech (Suzhou, China) Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did CGeneTech (Suzhou, China) Co. last raise money?
CGeneTech (Suzhou, China) Co.'s most recent round on record is a Series C, in Sep 2024.
What does CGeneTech (Suzhou, China) Co. do?
, Ltd operates as a small molecule innovative drug developer that integrates R&D, production and clinical trial services.
Where is CGeneTech (Suzhou, China) Co. headquartered?
CGeneTech (Suzhou, China) Co. is headquartered in Suzhou, China.
Which VCs invest in companies like CGeneTech (Suzhou, China) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CGeneTech (Suzhou, China) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like CGeneTech (Suzhou, China) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.